CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses
Research and development	$ 52,136	$ 59,201
General and administrative	26,997	29,948
Total operating expenses	79,133	89,149
Loss from operations	(79,133)	(89,149)
Other income, net
Other income, net	2,729	927
Total other income, net	2,729	927
Net loss	(76,404)	(88,222)
Comprehensive loss	$ (76,404)	$ (88,222)
Net loss per share, basic (in dollars per share)	$ (2.78)	$ (3.22)
Net loss per share, diluted (in dollars per share)	$ (2.78)	$ (3.22)
Weighted average common shares outstanding, basic (in shares)	27,496,107	27,392,087
Weighted average common shares outstanding, diluted (in shares)	27,496,107	27,392,087